Literature DB >> 6180666

Peptide radioimmunoassays in clinical medicine.

M C Geokas, R S Yalow, E W Straus, E M Gold.   

Abstract

The radioimmunoassay technique, first developed for the determination of hormones, has been applied to many substances of biologic interest by clinical and research laboratories around the world. It has had an enormous effect in medicine and biology as a diagnostic tool, a guide to therapy, and a probe for the fine structure of biologic systems. For instance, the assays of insulin, gastrin, secretin, prolactin, and certain tissue-specific enzymes have been invaluable in patient care. Further refinements of current methods, as well as the emergence of new immunoassay techniques, are expected to enhance precision, specificity, reliability, and convenience of the radioimmunoassay in both clinical and research laboratories.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180666     DOI: 10.7326/0003-4819-97-3-389

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  3 in total

1.  Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3,5,3'-triiodothyronine and dexamethasone on thyrotropin secretion.

Authors:  S W Lamberts; R Oosterom; T Verleun; E P Krenning; H Assies
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

2.  A radioimmunoassay for cholecystokinin (CCK).

Authors:  F P Brooks
Journal:  Dig Dis Sci       Date:  1983-05       Impact factor: 3.199

3.  An integrated peptide-antigen microarray on plasmonic gold films for sensitive human antibody profiling.

Authors:  Bo Zhang; Justin A Jarrell; Jordan V Price; Scott M Tabakman; Yanguang Li; Ming Gong; Guosong Hong; Ju Feng; Paul J Utz; Hongjie Dai
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.